Vorsetuzumab mafodotin
Product Specifications
Bioactivity
Vorsetuzumab mafodotin, a humanized anti-CD70 monoclonal antibody, conjugates with monomethyl auristatin F (MMAF) through Seattle Genetics' proprietary antibody-drug conjugate (ADC) technology. This affinity allows targeting of various solid tumors and cancers such as renal cell carcinoma, pancreatic, ovarian, and lung cancers, alongside multiple myeloma and several forms of non-Hodgkin lymphoma, all of which express CD70.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1054942-01 0.02 mg (E-Coli)
Recombinant Buchnera aphidicola subsp. Acyrthosiphon pisum Homoserine kinase (thrB)
Ask
View Details MBS1054942-02 0.02 mg (Yeast)
Recombinant Buchnera aphidicola subsp. Acyrthosiphon pisum Homoserine kinase (thrB)
Ask
View Details 
MBS1054942-03 0.1 mg (E-Coli)
Recombinant Buchnera aphidicola subsp. Acyrthosiphon pisum Homoserine kinase (thrB)
Ask
View Details MBS1054942-04 0.1 mg (Yeast)
Recombinant Buchnera aphidicola subsp. Acyrthosiphon pisum Homoserine kinase (thrB)
Ask
View Details